AI Science Tracker
EN

Department of Pharmaceutical Outcomes and Policy

1 discovery from 2022

Discoveries

Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.

Source check: Source checked. Not independent scientific confirmation.

Finding: Registry models predict DAA failure among 6,525 treated HCV patients, with 308 failures and reported discrimination beyond logistic regression; this is a bounded retrospective clinical outcome result.

Technology: Methods train elastic net, random forest, gradient boosting and feed-forward neural-network models on HCV-TARGET treatment data.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods train elastic net, random forest, gradient boosting and feed-forward neural-network models on HCV-TARGET treatment data.
Test and result
Results report 308 failures among 6,525 adults and C-statistics 0.72–0.75 for ML vs 0.51 logistic regression.
Limitation / still unknown
Registry outcome is DAA failure; retrospective prediction has modest discrimination and no prospective deployment result.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-022-22819-4 · https://pubmed.ncbi.nlm.nih.gov/36302828/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.